GSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients
-
Published:2019-04
Issue:2
Volume:8
Page:655-663
-
ISSN:2218-676X
-
Container-title:Translational Cancer Research
-
language:
-
Short-container-title:Transl. Cancer Res
Author:
Zhang Guochun,Qian Xueke,Ren Chongyang,Wen Lingzhu,Lyu Haitong,Liao Ning
Publisher
AME Publishing Company
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology